Thyrotropin-releasing hormone (TRH) analogues show enhanced CNS selectivity because of increased biological stability
- 1 September 1981
- journal article
- research article
- Published by Elsevier in Regulatory Peptides
- Vol. 2 (5), 277-284
- https://doi.org/10.1016/0167-0115(81)90032-x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- IS THYROTROPIN RELEASING HORMONE AN ENDOGENOUS ERGOTROPIC SUBSTANCE IN THE BRAIN?The Lancet, 1981
- TRH degradation rates vary widely between different animal speciesBiochemical Pharmacology, 1981
- Metabolism and pharmacokinetics of TRH and an analogue with enhanced neuropharmacological potencyNeuropeptides, 1981
- Biological evaluation of a TRH analogue with a modified proline residueNeuropharmacology, 1980
- An analogue of thyrotropin releasing hormone with improved biological stability both in vitro and in vivoBiochemical Pharmacology, 1980
- Modification of the proline residue of TRH enhances biological activity and inhibits degradationEuropean Journal of Pharmacology, 1980
- On the neuropharmacology of thyrotropin releasing hormone (TRH)Progress in Neurobiology, 1979
- Thyrotropin Releasing Hormone: Enhancement of Dopa Activity by a Hypothalamic HormoneScience, 1972
- New Tables for Multiple Comparisons with a ControlBiometrics, 1964